Danish cannabis firm quarantines more products from CannTrust
11/07/2019 11:26
COPENHAGEN, July 11 (Reuters) - Danish cannabis firm
StenoCare STENO.TE said on Thursday it would quarantine more
batches of cannabis oil from its partner CannTrust TRST.TO
which has sold products from what Canada's federal health
regulator called unlicensed facilities. urn:newsml:reuters.com:*:nL2N24B140
StenoCare said it would now quarantine five batches of the
oil, up from just one yesterday.
"The most likely consequence from this new situation is that
there will be a temporary shortage of medical cannabis products
to the Danish market," StenoCare said in a statement.
StenoCare's shares, which were listed in Stockholm in
October 2018, fell as much as 30% in early trading before
recovering to stand around 8% lower by 1015 GMT.
Denmark has legalised the medicinal use of cannabis for a
trial period and is also one of the few European nations to
legalise local production. Recreational use is still prohibited
even though Copenhagen's Christiania district is famous for
cannabis-selling booths which are rarely targeted by the
authorities.
StenoCare could not say how much of the cannabis oil in
question had reached consumers but said all products had been
tested and met required health standards.
(Reporting by Andreas Mortensen; Editing by Kirsten Donovan)
((andreas.mortensen@thomsonreuters.com; +45 33 96 96 75;))